Literature DB >> 36272991

Pseudogenes and the associated ceRNA network as potential prognostic biomarkers for colorectal cancer.

Zhuoqi Li1, Jing Zhou1, Liankun Gu1, Baozhen Zhang2.   

Abstract

Colorectal cancer (CRC) is one of the most common and malignant carcinomas. Many long noncoding RNAs (lncRNAs) have been reported to play important roles in the tumorigenesis of CRC by influencing the expression of some mRNAs via competing endogenous RNA (ceRNA) networks and interacting with miRNAs. Pseudogene is one kind of lncRNA and can act as RNA sponges for miRNAs and regulate gene expression via ceRNA networks. However, there are few studies about pseudogenes in CRC. In this study, 31 differentially expressed (DE) pseudogenes, 17 DE miRNAs and 152 DE mRNAs were identified by analyzing the expression profiles of colon adenocarcinoma obtained from The Cancer Genome Atlas. A ceRNA network was constructed based on these RNAs. Kaplan-Meier analysis showed that 7 pseudogenes, 4 miRNAs and 30 mRNAs were significantly associated with overall survival. Then multivariate Cox regression analysis of the ceRNA-related DE pseudogenes was performed and a 5-pseudogene signature with the greatest prognostic value for CRC was identified. Moreover, the results were validated by the Gene Expression Omnibus database, and quantitative real-time PCR in 113 pairs of CRC tissues and colon cancer cell lines. This study provides a pseudogene-associated ceRNA network, 7 prognostic pseudogene biomarkers, and a 5-pseudogene prognostic risk signature that may be useful for predicting the survival of CRC patients.
© 2022. The Author(s).

Entities:  

Year:  2022        PMID: 36272991     DOI: 10.1038/s41598-022-22768-y

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.996


  42 in total

Review 1.  ceRNA in cancer: possible functions and clinical implications.

Authors:  Xiaolong Qi; Da-Hong Zhang; Nan Wu; Jun-Hua Xiao; Xiang Wang; Wang Ma
Journal:  J Med Genet       Date:  2015-09-10       Impact factor: 6.318

Review 2.  The molecular pathogenesis of colorectal cancer and its potential application to colorectal cancer screening.

Authors:  William M Grady; Sanford D Markowitz
Journal:  Dig Dis Sci       Date:  2014-12-10       Impact factor: 3.199

3.  Colorectal cancer statistics, 2020.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ann Goding Sauer; Stacey A Fedewa; Lynn F Butterly; Joseph C Anderson; Andrea Cercek; Robert A Smith; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2020-03-05       Impact factor: 508.702

Review 4.  Pseudogenes: newly discovered players in human cancer.

Authors:  Laura Poliseno
Journal:  Sci Signal       Date:  2012-09-18       Impact factor: 8.192

Review 5.  Non-coding RNA networks in cancer.

Authors:  Eleni Anastasiadou; Leni S Jacob; Frank J Slack
Journal:  Nat Rev Cancer       Date:  2017-11-24       Impact factor: 60.716

6.  Long non-coding RNAs in colorectal cancer: Novel oncogenic mechanisms and promising clinical applications.

Authors:  Yufei Yang; Xuebing Yan; Xinxiang Li; Yanlei Ma; Ajay Goel
Journal:  Cancer Lett       Date:  2021-02-10       Impact factor: 8.679

7.  Cancer statistics, 2020.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2020-01-08       Impact factor: 508.702

8.  A coding-independent function of gene and pseudogene mRNAs regulates tumour biology.

Authors:  Laura Poliseno; Leonardo Salmena; Jiangwen Zhang; Brett Carver; William J Haveman; Pier Paolo Pandolfi
Journal:  Nature       Date:  2010-06-24       Impact factor: 49.962

Review 9.  MicroRNAs and 'Sponging' Competitive Endogenous RNAs Dysregulated in Colorectal Cancer: Potential as Noninvasive Biomarkers and Therapeutic Targets.

Authors:  Brian G Jorgensen; Seungil Ro
Journal:  Int J Mol Sci       Date:  2022-02-16       Impact factor: 5.923

10.  Exosomal miR-21 regulates the TETs/PTENp1/PTEN pathway to promote hepatocellular carcinoma growth.

Authors:  Liang-Qi Cao; Xue-Wei Yang; Yu-Bin Chen; Da-Wei Zhang; Xiao-Feng Jiang; Ping Xue
Journal:  Mol Cancer       Date:  2019-10-27       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.